Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial)

被引：0

作者：

Kiyotaka Okuno

Toru Aoyama

Koji Oba

Noboru Yokoyama

Nobuhisa Matsuhashi

Katsuyuki Kunieda

Yoji Nishimura

Hiroki Akamatsu

Takaya Kobatake

Satoshi Morita

Takaki Yoshikawa

Junichi Sakamoto

Shigetoyo Saji

机构：

[1] Kindai University Faculty of Medicine,Department of Surgery

[2] Yokohama City University Yokoham,Department of Surgery

[3] The University of Tokyo,Department of Biostatistics

[4] Showa University Koto Toyosu Hospital,Digestive Disease Center

[5] Gifu University,Department of Surgical Oncology

[6] Gifu Prefectural General Medical Center,Department of Surgery

[7] Saitama Cancer Cancer,Department of Gastroenterological Surgery

[8] Osaka Police Hospital,Department of Surgery

[9] Shikoku Cancer Center Hospital,Department of Surgery

[10] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics

[11] Kanagawa Cancer Center,Department of Gastrointestinal Surgery

[12] Japanese Foundation for Multidisciplinary Treatment of Cancer,undefined

[13] Tokai Central Hospital,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2018年 / 81卷

关键词：

Rectal cancer; PSK; UFT, RFS, OS;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：65 / 71

页数：6

共 123 条

[11] Folkesson J(2004)Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up Int J Colorectal Dis 19 157-1010
[12] Birgisson H(2004)Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study Br J Cancer 90 1003-40
[13] Pahlman L(1994)Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion Am J Surg 168 36-624
[14] Kim MB(2016)The efficacy of adjuvant immunochemotherapy with OK-432 after curative resection of gastric cancer: an individual patient data meta-analysis of randomized controlled trials Gastric Cancer 19 616-171
[15] Hong TS(2016)Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701) Eur J Cancer 65 164-766
[16] Wo JY(2002)Trends in longterm survival following liver resection for hepatic colorectal metastases Ann Surg 235 759-914
[17] Oki E(2001)Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med 343 905-undefined
[18] Ando K(undefined)undefined undefined undefined undefined-undefined
[19] Kasagi Y(undefined)undefined undefined undefined undefined-undefined
[20] Zaitsu Y(undefined)undefined undefined undefined undefined-undefined